This inventor holds 1 USPTO granted patent. Top assignee: Mitsubishi Chemical Corporation. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Innovations of Jingping Qu in Pharmaceutical Chemistry
Introduction
Jingping Qu is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patent that focuses on synthesis intermediates for pharmaceutical preparations.
Latest Patents
Jingping Qu holds a patent for "3-Hydroxy-3-(2-thienyl) propionamides and production method thereof, and production method of 3-amino-1-(2-thienyl)-1-propanols using the same." This invention aims to provide 3-hydroxy-3-(2-thienyl) propionamides that are useful as synthesis intermediates in pharmaceutical applications. The method described in the patent allows for the production of optically active 3-amino-1-(2-thienyl)-1-propanols with high reaction yield, high optical yield, and at an industrially low cost. The process involves asymmetric reduction of a β-ketocarbonyl compound containing a thiophene ring, utilizing a catalyst from a group VIII or IX metal, along with a specified optically active diamine derivative.
Career Highlights
Jingping Qu is associated with Mitsubishi Chemical Corporation, where he has been able to apply his expertise in pharmaceutical chemistry. His work has contributed to advancements in the synthesis of important pharmaceutical compounds.
Collaborations
Jingping Qu has collaborated with notable colleagues such as Jun Takehara and Kazuaki Kanno, enhancing the research and development efforts within his field.
Conclusion
Jingping Qu's innovative work in pharmaceutical chemistry, particularly through his patent on 3-hydroxy-3-(2-thienyl) propionamides, showcases his significant contributions to the industry. His efforts continue to influence the development of effective pharmaceutical preparations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile